Pituitary

Excess mortality for patients with residual disease following resection of pituitary adenomas.

Pituitary

Sughrue ME, Chang EF, Gabriel RA, Aghi MK, Blevins LS

Long term outcome following repeat transsphenoidal surgery for recurrent endocrine-inactive pituitary adenomas.

Pituitary

Chang EF, Sughrue ME, Zada G, Wilson CB, Blevins LS, Kunwar S

Pre-operative dopamine agonist therapy improves post-operative tumor control following prolactinoma resection.

Pituitary

Sughrue ME, Chang EF, Tyrell JB, Kunwar S, Wilson CB, Blevins LS

Support Engineering Innovations at UCSF